The Quality of Life and Related Psychosocial Factors of Schizophrenia Patients Registered in Community Mental Health Center

지역 정신보건센터에 등록된 조현병 환자의 삶의 질 및 관련 정신사회적 요인

  • Jang, Chang Hyun (Department of Psychiatry & Institute of Mental Health, College of Medicine, Hanyang University) ;
  • Ahn, Dong Hyun (Department of Psychiatry & Institute of Mental Health, College of Medicine, Hanyang University) ;
  • Lee, Jeong Im (Seongdong Mental Health Center)
  • 장창현 (한양대학교 의과대학 정신건강의학교실, 정신건강연구소) ;
  • 안동현 (한양대학교 의과대학 정신건강의학교실, 정신건강연구소) ;
  • 이정임 (성동구정신건강증진센터)
  • Received : 2013.06.13
  • Accepted : 2014.02.06
  • Published : 2014.02.28

Abstract

Objectives This study aimed to identify the relationship between quality of life (QoL) and psychosocial factors of schizophrenia patients registered in a community mental health center. Methods The ninety patients with schizophrenia, diagnosed by Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition-Text Revision, registered in a community mental health center were studied cross-sectionally. Four trained personnels interviewed each subject individually for the assessment of QoL, psychopathology, severity of depressed mood, insight of illness, attitude toward drugs, social function, degree of social supports and conflicts. Results QoL was significantly related to the psychopathology, depressed mood, social conflict, social support; and other aspects of QoL were slightly differently related to depressed mood, social conflict, social support and attitude toward drug by scales. In multiple regression analysis, depressed mood (20.0%) and social conflict (10.3%) were contributed to QoL assessed by Korean version of 4th revision of Schizophrenia Quality of Life. Social support (21.4%), social conflict (20.9%) and depressed mood (3.1%) were contributed to QoL assessed by Korean modification of the Scale to measure Subjective Well-being under Neuroleptic treatment. Conclusions These findings demonstrated that QoL of schizophrenia patients in a community is affected by depressed mood, social support and conflict rather than psychotic symptoms, insight and attitude toward drugs. And this result suggests the necessity of approaching not only to the psychotic symptoms but also to the psychosocial characteristics in caring schizophrenia patients in the community.

Keywords

References

  1. Davies LM, Drummond MF. Economics and schizophrenia: the real cost. Br J Psychiatry Suppl 1994;(25):18-21.
  2. Awad AG, Voruganti LN. Quality of life and new antipsychotics in schizophrenia. Are patients better off? Int J Soc Psychiatry 1999; 45:268-275. https://doi.org/10.1177/002076409904500405
  3. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995;41:1403-1409. https://doi.org/10.1016/0277-9536(95)00112-K
  4. Lehman AF. The well-being of chronic mental patients. Arch Gen Psychiatry 1983;40:369-373. https://doi.org/10.1001/archpsyc.1983.01790040023003
  5. Voruganti L, Heslegrave R, Awad AG, Seeman MV. Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability. Psychol Med 1998;28:165-172. https://doi.org/10.1017/S0033291797005874
  6. Lee KU, Bahk WM. A new goal of treatment for schizophrenia: quality of life. Korean J Psychopharmacol 2006;17:13-23.
  7. Choi JW, Hong JP, Kim CY, Lee C, Han OS. Quality of life in the first admitted schizophrenic patients: a retrospective follow-up study. J Korean Neuropsychiatr Assoc 1997;36:987-996.
  8. Yoo HJ, Yoon DJ, Shin YW, Bahn G, Kim JW. Quality of life and insight in patients with schizophrenia. J Korean Neuropsychiatr Assoc 1999;38:340-348.
  9. Kim JH, Yoon JH, Lee JY, No KH, Hong SK, Yoon SC, et al. Subjective quality of life in schizophrenic psychopathology, adverse drug effects and subjective response to drug. J Korean Neuropsychiatr Assoc 2003;42:222-230.
  10. Suh HS, Kim CH, Lee HS, Jung YC, Choi YH, Huh SY, et al. Quality of life and psychopathology in patients with schizophrenia: subjective and objective assessment. J Korean Neuropsychiatr Assoc 2001; 40:1122-1131.
  11. Kim KJ, Seol JH, Paik YS, Kim JH. The relationship between quality of life and psychosocial characteristics in patients with schizophrenia. J Korean Neuropsychiatr Assoc 2004;43:603-610.
  12. Han KY. The relationship between quality of life and symptoms in community-resident schizophrenic patients [dissertation]. Suwon: Ajou University;2002.
  13. Ministry of Health & Welfare. 2011 Guideline for Mental Health Project. Sejong: Ministry of Health & Welfare;2011. p.5-23.
  14. Yeung FK, Chan SH. Clinical characteristics and objective living conditions in relation to quality of life among community-based individuals of schizophrenia in Hong Kong. Qual Life Res 2006;15:1459-1469. https://doi.org/10.1007/s11136-006-0006-z
  15. Wilkinson G, Hesdon B, Wild D, Cookson R, Farina C, Sharma V, et al. Self-report quality of life measure for people with schizophrenia: the SQLS. Br J Psychiatry 2000;177:42-46. https://doi.org/10.1192/bjp.177.1.42
  16. Naber D. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol 1995;10 Suppl 3:133-138.
  17. Kim JH, Yim SJ, Min SK, Kim SE, Son SJ, Wild DJ, et al. The Korean Version of 4th Revision of Schizophrenia Quality of Life Scale: validation study and relationship with PANSS. J Korean Neuropsychiatr Assoc 2006;45:401-410.
  18. Naber D, Walther A, Kircher T, Hayek D, Holzbach R. Subjective effects of neuroleptics predict compliance. In: Gaebel W, Awad H, editors. Prediction of Neuroleptic Treatment Outcome in Schizophrenia: Concepts and Methods. Wien: Springer-Verlag;1994. p.85-98.
  19. Yoon JS, Kook SH, Lee HY, Lee C, Paik IH. The development of a Korean modification of the scale to measure subjective well-being under neuroleptic treatment (KmSWN). J Korean Neuropsychiatr Assoc 2000;39:987-998.
  20. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep 1962;10:799-812. https://doi.org/10.2466/pr0.1962.10.3.799
  21. Leucht S, Kane JM, Etschel E, Kissling W, Hamann J, Engel RR. Linking the PANSS, BPRS, and CGI: clinical implications. Neuropsychopharmacology 2006;31:2318-2325.
  22. Addington D, Addington J, Maticka-Tyndale E, Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophr Res 1992;6:201-208. https://doi.org/10.1016/0920-9964(92)90003-N
  23. Kim YK, Won SD, Lee KM, Choi HS, Jang HS, Lee BH, et al. A study on the reliability and validity of the Korean Version of the Calgary Depression Scale for Schizophrenia (K-CDSS). J Korean Neuropsychiatr Assoc 2005;44:446-455.
  24. Amador XF, Flaum M, Andreasen NC, Strauss DH, Yale SA, Clark SC, et al. Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry 1994;51:826-836. https://doi.org/10.1001/archpsyc.1994.03950100074007
  25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. 4th ed. Washington, DC: American Psychiatric Association;2000. p.817-818.
  26. Abbey A, Abramis DJ, Caplan RD. Effects of different sources of social support and social conflict on emotional well-being. Basic Appl Soc Psych 1985;6:111-129. https://doi.org/10.1207/s15324834basp0602_2
  27. Chun CA. Effects of postpartum stress and social network on postpartum depression [dissertation]. Seoul: Korea University;1990.
  28. You SE, Kwon JH. The effects of perfectionism, social support, stress, and coping style on depression in the middle-aged woman. Korean J Clin Psychol 1997;16:67-84.
  29. Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 1983;13:177-183. https://doi.org/10.1017/S0033291700050182
  30. Awad AG. Quality of life issues in medicated schizophrenic patients. In: Shriqui CL, Nasrallah HA, editors. Contemporary Issues in the Treatment of Schizophrenia. Washington, DC: American Psychiatric Press.;1995. p.735-748.
  31. Lehman AF. A quality of life interview for the chronically mentally ill. Eval Program Plann 1988;11:51-62. https://doi.org/10.1016/0149-7189(88)90033-X
  32. Carpiniello B, Lai GL, Pariante CM, Carta MG, Rudas N. Symptoms, standards of living and subjective quality of life: a comparative study of schizophrenic and depressed out-patients. Acta Psychiatr Scand 1997;96:235-241. https://doi.org/10.1111/j.1600-0447.1997.tb10157.x
  33. Lehman AF, Burns BJ. Severe mental illness in the community. In: Spilker B, editor. Quality of Life Assessments in Clinical Trials. Philadelphia: Lippincott-Raven;1996. p.922-924.
  34. Mauriño J, Sanjúan J, Haro JM, Díez T, Ballesteros J. Impact of depressive symptoms on subjective well-being: the importance of patient- reported outcomes in schizophrenia. Patient Prefer Adherence 2011;5:471-474.
  35. Hofer A, Kemmler G, Eder U, Edlinger M, Hummer M, Fleischhacker WW. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects. J Clin Psychiatry 2004;65:932-939. https://doi.org/10.4088/JCP.v65n0709
  36. Baek SB, Kim JH, Shim JH, Shin YC, Noh KS, Lee SH, et al. Multidimensional insight and outcome in schizophrenia patients. Kor J Psychopathol 1997;6:263-271.
  37. Ritsner M, Modai I, Endicott J, Rivkin O, Nechamkin Y, Barak P, et al. Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients. J Clin Psychiatry 2000;61:880-889; quiz 890. https://doi.org/10.4088/JCP.v61n1113
  38. Caron J, Lecomte Y, Stip E, Renaud S. Predictors of quality of life in schizophrenia. Community Ment Health J 2005;41:399-417. https://doi.org/10.1007/s10597-005-5077-8
  39. Yang DS, Kook SH, Choi Y, Lee HY. The relations among sociodemographic, clinical and psychological characteristics and quality of life in patients with psychotic disorders and their caregivers. Korean Neuropsychiatr Assoc 2001;40:1044-1054.
  40. Solomon P. Moving from psychoeducation to family education for families of adults with serious mental illness. Psychiatr Serv 1996; 47:1364-1370. https://doi.org/10.1176/ps.47.12.1364